Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-23-012882

Options or other derivatives

  • Chief Medical Officer acquired 550,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Neuman Linda L Chief Medical Officer 2023-02-23 Grant or award · Employee Stock Option (right to buy) +550,000 550,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…